S. Bojin

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept study

Mark C. Genovese, Filip Van den Bosch, Stephanie Roberson et al. · Arthritis & Rheumatism · 2010 · 450 citations

Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial

Paul P. Tak, Andra Bălănescu, Vira Tseluyko et al. · Annals of the Rheumatic Diseases · 2012 · 98 citations

Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo‐Controlled Trial

Mark C. Genovese, S. Bojin, Ilaria Biagini et al. · Arthritis & Rheumatism · 2013 · 69 citations